Siegfried Holding AG (0QQO.L)

CHF 978.56

(0.57%)

Operating Expenses Summary of Siegfried Holding AG

  • Siegfried Holding AG's latest annual operating expenses in 2023 was 148.34 Million CHF , up 66.62% from previous year.
  • Siegfried Holding AG's latest quarterly operating expenses in 2024 Q2 was 71.66 Million CHF , down 0.0% from previous quarter.
  • Siegfried Holding AG reported a annual operating expenses of 91.07 Million CHF in annual operating expenses 2022, down -16.63% from previous year.
  • Siegfried Holding AG reported a annual operating expenses of 109.24 Million CHF in annual operating expenses 2021, up 10.8% from previous year.
  • Siegfried Holding AG reported a quarterly operating expenses of 72.33 Million CHF for 2023 Q2, down 0.0% from previous quarter.
  • Siegfried Holding AG reported a quarterly operating expenses of 151.74 Million CHF for 2023 FY, up 66.62% from previous quarter.

Annual Operating Expenses Chart of Siegfried Holding AG (2023 - 2002)

Historical Annual Operating Expenses of Siegfried Holding AG (2023 - 2002)

Year Operating Expenses Operating Expenses Growth
2023 148.34 Million CHF 66.62%
2022 91.07 Million CHF -16.63%
2021 109.24 Million CHF 10.8%
2020 98.59 Million CHF -16.2%
2019 117.65 Million CHF 41.79%
2018 82.97 Million CHF 7.36%
2017 77.28 Million CHF 15.85%
2016 66.71 Million CHF 38.01%
2015 48.33 Million CHF 24.1%
2014 38.95 Million CHF -15.74%
2013 46.22 Million CHF -34.65%
2012 70.73 Million CHF 31.41%
2011 53.82 Million CHF 14.15%
2010 47.15 Million CHF -20.13%
2009 59.04 Million CHF 17.79%
2008 50.12 Million CHF -31.68%
2007 73.37 Million CHF 33.64%
2006 54.9 Million CHF -8.98%
2005 60.32 Million CHF -21.3%
2004 76.65 Million CHF 22.05%
2003 62.8 Million CHF -14.15%
2002 73.15 Million CHF 0.0%

Peer Operating Expenses Comparison of Siegfried Holding AG

Name Operating Expenses Operating Expenses Difference
Relief Therapeutics Holding AG 114.94 Million CHF -29.058%
Tecan Group AG 254.49 Million CHF 41.713%
Santhera Pharmaceuticals Holding AG 31.33 Million CHF -373.4%
Basilea Pharmaceutica AG 111.63 Million CHF -32.879%
Bachem Holding AG 47.58 Million CHF -211.75%
Molecular Partners AG 20.3 Million CHF -630.667%